In genetic analysis, there are often competing explanations for the same data. Sophisticated mathematical models have been developed that can encapsulate these problems in terms of parameters that ...
The customary approach to early-phase clinical trial design, where the focus is on identification of the maximum tolerated dose, is not always suitable for noncytotoxic or other targeted therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results